Answers are grounded in this paper and cite their sources.
Novel convenient, reliable, and label-free approaches for bleomycin (BLM) quantification are highly needed to support clinical treatment of some cancers. Herein, we reported a label-free luminescent probe for sensing BLM utilizing a guanine/thymine-enriched DNA ([G3T]5)-sensitized Tb3+ luminescence for the first time. Benefiting from the antenna effect, the [G3T]5 sequence efficiently amplified Tb3+ luminescence by approximately 135-fold via energy transfer from [G3T]5 to Tb3+. In addition, [G3T]5 harbored the specific cleavage site recognized by BLM. When the BLM-Fe(II) complex was introduced, [G3T]5 was fragmented into short oligonucleotides that failed to activate Tb3+ luminescence enhancement. On this basis, Tb3+-[G3T]5 assembly was exploited to detect BLM sensitively with a limit of detection of 0.76 nM. Furthermore, this facile sensing platform was successfully implemented for BLM quantification in serum samples.
No takes yet. Share an insight, caveat, or question.
Hongwei Peng (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: